Claritev
CTEV | NYSE
$24.99
-$1.83 (-6.82%)
At close: Nov 16, 2026, 4:00 PM ET
$24.99
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:01 PM ET
Claritev Company Profile
Company profile explainedCompany Profile
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
Key Executives
| Name | Position |
|---|---|
| Travis S. Dalton | Chief Executive Officer, President & Chairman |
| Carol H. Nutter | Senior Vice President & Chief People Officer |
| Douglas Garis | Executive Vice President & Chief Financial Officer |
| Jerome W. Hogge | Executive Vice President & Chief Operating Officer |
| Tara A. O'Neil | Chief Legal Officer |
| Alwyn Van Heerdan | Vice President of Strategy & Corporate Development |
| Brock Albinson | Senior Vice President & Chief Accounting Officer |
| Jason Wong | Senior Vice President of Treasury & Investor Relations |
| Kristen Lambert-Kennedy | Chief Compliance & Chief Privacy Officer |
| Melissa Humphrey | Senior Vice President of Marketing & Communications |
| Michael C. Kim | Executive Vice President & Chief Digital Officer |
| Tiffani D. Misencik | Senior Vice President & Chief Growth Officer |
| Todd Friedman | Head of IR & Strategic Communications |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2026 | 4 | Filing |
| Oct 27, 2026 | 4 | Filing |
| Oct 19, 2026 | 4 | Filing |
| Oct 19, 2026 | 3 | Filing |
| Oct 16, 2026 | 4 | Filing |
| Oct 15, 2026 | 8-K | Current Report |
| Oct 01, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Sep 22, 2026 | 4 | Filing |
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 3 | Filing |
Claritev
| Country | United States |
| IPO Date | Apr 3, 2020 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 3,000 |
| CEO | Travis S. Dalton |
Contact Details
7900 Tysons One Place McLean,
Virginia 22102 United States
Stock Details
| Ticker Symbol | CTEV |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001793229 |
| CUSIP Number | 62548M209 |
| ISIN Number | US62548M2098 |
| SIC Code | 7389 |
Add to Watchlist
Select watchlists to add or remove CTEV